World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: REBEC
Last refreshed on: 29 April 2013
Main ID:  RBR-7zmz55
Date of registration: 03/07/2011
Primary sponsor: PUC Minas - Brazil
Public title: Light therapy for treatment of lesions of the nipple
Scientific title: Photobiomodulation as a new approach for the treatmment of nipple traumas: a pilot study
Date of first enrolment:
Target sample size: 10
Recruitment status: recruitment completed
URL:  http://www.ensaiosclinicos.gov.br/rg/RBR-7zmz55/
Study type: 
Study design:  Clinical trial (pilot study), randomized, phase 1-2, with two arms.  
Countries of recruitment
Brazil
Contacts
Name: Angélica  Araújo
Address:  Avenida Trinta e Um de Março, Acesso 7, Prédio 46 - Bairro Dom Cabral 30.535-000 Belo Horizonte Brazil
Telephone: (31)3319-4425
Email: angelica@bios.srv.br
Affiliation:  PUC Minas
Name: Angélica  Araújo
Address:  Avenida Trinta e Um de Março, Acesso 7, Prédio 46 - Bairro Dom Cabral 30.535-000 Belo Horizonte Brazil
Telephone: (31)3319-4425
Email: angelica@bios.srv.br
Affiliation:  PUC Minas
Key inclusion & exclusion criteria
Inclusion criteria: To participate in the study, women should have a medical diagnosis of nipple trauma were not infected and aged 18 to 35 years.
Exclusion criteria: Exclusion criteria was considered: previous history of cancer; use of other therapeutic modalities that might interfere with the healing of the lesions; presence of infected wounds; history of photosensitivity to light; cognitive deficits that undermine the understanding and implementation of guidelines of care for breast.

Age minimum: 18Y
Age maximum: 35Y
Gender: F
Health Condition(s) or Problem(s) studied
Injuries to the nipple (fissures and cracks) resulting breastfeeding
F01.145.407.199
Intervention(s)
Participants will be randomly assigned to one of two treatment groups: control or experimental. The control group will receive guidance on breastfeeding and the experimental group will receive, in addition, applications of phototherapy.
Control group (orientation): the participants of this group receive individual guidance on the care and proper techniques for breast feeding. The information will be passed verbally and reinforced by an educational brochure on initial assessment, the third and sixth weeks of the study, always by the same professional, blind to treatment group the participant.
Experimental group (orientation, light therapy): the participants of this group will receive, in addition to guidance on the breast care and proper techniques for feeding, phototherapy applications through fotobiomodulador a device developed specifically for the treatment of nipple injuries. The parameters for applications are: continuous mode of emission, power output 10 mW, wavelength infrared (scanning from 880 to 904 nm) fluence of 4 J / cm ² and total application time of 10 minutes.
The application of the device will be three times per week on alternate days for seven consecutive weeks, totaling 21 sessions.
Primary Outcome(s)
Pain: pain intensity will be evaluated using the Visual Numeric Scale (VNS). The EVN will be applied at baseline and at the beginning of each week of treatment, for six consecutive weeks.
Size and classification of injuries: wounds nipple will be measured weekly in the initial assessment and for six consecutive weeks, using a digital caliper and classified at the beginning and end of treatment according to Pereira et al (1998). The measurements and classification of cracks will be conducted by a researcher previously trained to perform procedures.
Secondary Outcome(s)
Quality of life: the impact of the presence of nipple fissures and cracks in the quality of life of the mothers will be assessed by the SF-36 (short version), applied at baseline, in the third and sixth weeks of the study.
Secondary ID(s)
CAAE 0130.0.213.000-05
Source(s) of Monetary Support
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history